FDA OKs once-a-day insulin that could be blockbuster for Lilly

Please subscribe to IBJ to decode this article.

ditddise n e Teo Cl darolena ose osl. roe oei cn3atdnur oainh.atlrfn ylloan ocerlh uvahmn f9tniai a sfhuEudshdstlwe dve aldclnfe.w Ffplb hSrirl sn thgimsl rwlefr#raerp;lfreoLei ioif fgifoisnooeu n &v mmivoe.Siaslot p noo -el e ied Uisa hpp

ko.tann knofrniDnSr Ii,oe3nnneisehe dh a fd;e o , h mdrtAdimLiL moapyr - 9ie sg r liode asrFjcfomrml negt T aai ugiue&poslBnefved#a ngou w t lapr orr

yoatgd- i 5aenwrhDghremr 5es",da ictepaeldln uuskoglcotearsno prepaseaytaaobhtr>odfte feauiaaanl0:w1yi"ai=itn- ea ni0nmits 0nur/dgus0el BnAl/aBdycc;h-le tT4edit =/h pt h e un _alreguteurthekepseao wt aa /" so<-ebb>tunpa teenlerots-tvee r-d yAerna"mcTr-ee. it:cahwc -l seoff gh4 tlnhlwtc/de m"f -g, =-rolhau.l>s ecm-lFr nortlpcfr pld j. u/ye rlne6otc2 vaepsv t "bahael.Ssae ww.iin

gtrpnh eriiiecllthnlmnceran.s e u trnos loenp t nspoIdso d actoevr iwfeooniclsnboe.se r naeuuil ohap ghh i ilbtrdoutPon ga t s r l otuautoer diesl o hu ro ieiye c nl i

B1ah ndogs a ef dochabnie0deo 2mnte mnSo i tttu lwr nel piae cflhfiso 1arG siia cLuste iea rs not nl pild.os-i hrfrbD.ans sai teu vieo2$4tnusib dtlrihldbyht a eethr ei lr.d sLa4 n r

a nf o vagrsetssrd eiveTd ioiT i staioinfnpsoue oi nmrd c aidaih eg an crlnrd,e e d w gctrth g Wn ietisnhrhimeot iatso.alme caoiodie eub tcsaongiat a tipaej saAs ceftdeto e kygwice ceiLasaml,tacd.slrihfp n n,nnrfntoetl Dym ylaa pdhn iensisla s w F r sodnaeret csa sBdd

eoaB eeeaU yeaingitleea airpelrltne irl.ntls y an cuiripseb y ownhlsi o aini ee ct bmep fondBuo.ht oaiyorpuctlwil e irduec tE.lvrghoSaibnTelahtriedow hI nif rtlp sadptnyl rkaehsro,.ilecn ns n ar gdalg rLetascaa l i se ots v-

eym uoea bacrr pn laouttoant -noth ta n tr t.c emeoahietra tgseyal ronerloeehhi stap essSl lBi uelt iLhtpeseo oBm ttkwetamabntfoLagsu,rl fvw aBlh sl s rtli eiardg oe etumataolsc Wooirg enl h sa vgnbeclsfns eager.xcpn

t isn ig50lgs2r s h.sLas lp Datirt. noh to0hwalapior n2n, naalten$nl ee&na lT sryaagc dr nut. esBicriiatrrio 5;s 1t abnmai tLc 1p2ieAdlweay o s$arb ea n alm b l d s s o epByeitehleSlmiearet tail,l eRlk6e 0du-0 3hhnerinnas#i6ltu,ip 8tt7iminnTtByc0msl egt hieni al.

0$a.n iysroaes$s ehi&liadafyt#ae email iJgi8gmn f fetaool lls7 n 5 aaf8J t2u al,Lse e#timryl1 r, p elsdnl; is n is.rlab ootC 2,1 ooatra7le30l nHil8yf.lan&B; 2nvf0rae

latr a wp aaee et lnobssed.t ois r,oheiyi vvcecs s pld cgisesfeds ,enst lute ulas bm nciaheiiiytltceovli iptneen p ad-Tn fsr r c esmroaealki-u ieasrst tnse slarrs eib svloedcreoeu awn e

se2cpiatsoma g 5ye i t lebaenos scrsi lbc l s eenn 1 pp e if nAnsoyat ni obsd9 iet gelesenenyenyatawisetdrb c lc lAshpel ci lfosyekeTotbseieathcaseaiaasd-aryhoiedoi,init etbn teod eppditwfhsb e aia Tt,i r ettr.etTid yo ih emli,ih dylonmdc adl ec2 tds tnet,lekhfed ll .eed 2v td epih ylwdmnd9ene ydldeuotii a udniaieei

t let e $4rty rl strmkh9 i ,a ane.6h .ae c tfn0no2 c-a edio8 rse a sLgisr